Report cover image

Primary Biliary Cholangitis Global Market Opportunities And Strategies To 2034

Publisher The Business Research Company
Published May 20, 2025
Length 319 Pages
SKU # BRC20039782

Description

Primary Biliary Cholangitis Global Market Opportunities And Strategies To 2034 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global primary biliary cholangitis market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description:

Where is the largest and fastest-growing market for primary biliary cholangitis? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The primary biliary cholangitis market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider primary biliary cholangitis market; and compares it with other markets.

The report covers the following chapters
  • Introduction And Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by treatment type, by diagnosis and by end user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Growth Analysis And Strategic Analysis Framework- Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
  • Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by treatment type, by diagnosis and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by exchange model, by trading type, by coin or token and by payment method in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
  • Regional Market Size And Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
  • Recent Developments- Information on recent developments in the market covered in the report.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for primary biliary cholangitis providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.
Markets Covered:

1) By Treatment Type: Drugs; Liver Transplantation

2)By Diagnosis: Magnetic Resonance Elastography (MRE); Magnetic Resonance Cholangiopancreatography (MRCP); Ultrasound; Fibroscan; Cholesterol Test; Antibody Tests; Liver Tests; Other Diagnoses

3) By End User: Hospitals; Specialty Clinics; Homecare; Other End-Users

Companies Mentioned: Intercept Pharmaceuticals Inc.; Mayo Clinic Laboratories; University of Pittsburgh Medical Center (UPMC); Stanford Health Care; Duke University Hospital

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia; Africa

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; primary biliary cholangitis indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

319 Pages
1 Executive Summary
1.1 Primary Biliary Cholangitis – Market Attractiveness And Macro Economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 Primary Biliary Cholangitis Market Definition And Segmentations
6.4 Market Segmentation By Treatment Type
6.4.1 Drugs
6.4.2 Liver Transplantation
6.5 Market Segmentation By Diagnosis
6.5.1 Magnetic Resonance Elastography (MRE)
6.5.2 Magnetic Resonance Cholangiopancreatography (MRCP)
6.5.3 Ultrasound
6.5.4 Fibroscan
6.5.5 Cholesterol Test
6.5.6 Antibody Tests
6.5.7 Liver Tests
6.5.8 Other Diagnoses
6.6 Market Segmentation By End User
6.6.1 Hospitals
6.6.2 Specialty Clinics
6.6.3 Homecare
6.6.4 Other End-Users
7 Major Market Trends
7.1 Role Of Combination Therapy In Liver Disease Management
7.2 Advancements In Bile Acid Analog-Based Therapies
7.3 Strategic Partnerships Driving Innovation In PBC Treatment
8 Global Primary Biliary Cholangitis Growth Analysis And Strategic Analysis Framework
8.1 Global Primary Biliary Cholangitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
8.1.1 Political
8.1.2 Economic
8.1.3 Social
8.1.4 Technological
8.1.5 Environmental
8.1.6 Legal
8.2 Analysis Of End Use Industries
8.2.1 Hospitals And Specialty Clinics
8.2.2 Homecare
8.2.3 Diagnostic Laboratories
8.2.4 Pharmaceutical & Biotechnology Companies
8.2.5 Other End Users
8.3 Global Primary Biliary Cholangitis Market Growth Rate Analysis
8.4 Historic Market Growth, 2019 – 2024, Value ($ Million)
8.4.1 Market Drivers 2019 – 2024
8.4.2 Market Restraints 2019 – 2024
8.5 Forecast Market Growth, 2024 – 2029, 2034F Value ($ Million)
8.5.1 Market Drivers 2024 – 2029
8.5.2 Market Restraints 2024 – 2029
8.6 Forecast Growth Contributors/Factors
8.6.1 Quantitative Growth Contributors
8.6.2 Drivers
8.6.3 Restraints
8.7 Global Primary Biliary Cholangitis Total Addressable Market (TAM)
9 Global Primary Biliary Cholangitis Market Segmentation
9.1 Global Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.2 Global Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.3 Global Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.4 Global Primary Biliary Cholangitis Market, Sub-Segmentation Of Drugs, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
9.5 Global Primary Biliary Cholangitis Market, Sub-Segmentation By Liver Transplantation, By Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10 Primary Biliary Cholangitis Market, Regional and Country Analysis
10.1 Global Primary Biliary Cholangitis Market, By Region, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
10.2 Global Primary Biliary Cholangitis Market, By Country, Historic and Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11 Asia-Pacific Market
11.1 Summary
11.2 Market Overview
11.2.1 Region Information
11.2.2 Market Information
11.2.3 Background Information
11.2.4 Government Initiatives
11.2.5 Regulations
11.2.6 Regulatory Bodies
11.2.7 Major Associations
11.2.8 Taxes Levied
11.2.9 Corporate Tax Structure
11.2.10 Investments
11.2.11 Major Companies
11.3 Asia-Pacific Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.4 Asia-Pacific Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.5 Asia-Pacific Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.6 Asia-Pacific Primary Biliary Cholangitis Market: Country Analysis
11.7 China Market
11.8 Summary
11.9 Market Overview
11.9.1 Country Information
11.9.2 Market Information
11.9.3 Background Information
11.9.4 Government Initiatives
11.9.5 Regulations
11.9.6 Regulatory Bodies
11.9.7 Major Associations
11.9.8 Taxes Levied
11.9.9 Corporate Tax Structure
11.9.10 Investments
11.9.11 Major Companies
11.10 China Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.11 China Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.12 China Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.13 India Market
11.14 India Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.15 India Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.16 India Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.17 Japan Market
11.18 Summary
11.19 Market Overview
11.19.1 Country Information
11.19.2 Market Information
11.19.3 Background Information
11.19.4 Government Initiatives
11.19.5 Regulations
11.19.6 Regulatory Bodies
11.19.7 Major Associations
11.19.8 Taxes Levied
11.19.9 Corporate Tax Structure
11.19.10 Major Companies
11.20 Japan Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.21 Japan Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.22 Japan Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.23 Australia Market
11.24 Australia Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.25 Australia Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.26 Australia Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.27 Indonesia Market
11.28 Indonesia Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.29 Indonesia Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.30 Indonesia Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.31 South Korea Market
11.32 Summary
11.33 Market Overview
11.33.1 Country Information
11.33.2 Market Information
11.33.3 Background Information
11.33.4 Government Initiatives
11.33.5 Regulations
11.33.6 Regulatory Bodies
11.33.7 Major Associations
11.33.8 Taxes Levied
11.33.9 Corporate Tax Structure
11.33.10 Major Companies
11.34 South Korea Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.35 South Korea Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
11.36 South Korea Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12 Western Europe Market
12.1 Summary
12.2 Market Overview
12.2.1 Region Information
12.2.2 Market Information
12.2.3 Background Information
12.2.4 Government Initiatives
12.2.5 Regulations
12.2.6 Regulatory Bodies
12.2.7 Major Associations
12.2.8 Taxes Levied
12.2.9 Corporate tax structure
12.2.10 Investments
12.2.11 Major Companies
12.3 Western Europe Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.4 Western Europe Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.5 Western Europe Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.6 Western Europe Primary Biliary Cholangitis Market: Country Analysis
12.7 UK Market
12.8 UK Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.9 UK Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.10 UK Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.11 Germany Market
12.12 Germany Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.13 Germany Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.14 Germany Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.15 France Market
12.16 France Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.17 France Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.18 France Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.19 Italy Market
12.20 Italy Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.21 Italy Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.22 Italy Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.23 Spain Market
12.24 Spain Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.25 Spain Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
12.26 Spain Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13 Eastern Europe Market
13.1 Summary
13.2 Market Overview
13.2.1 Region Information
13.2.2 Market Information
13.2.3 Background Information
13.2.4 Government Initiatives
13.2.5 Regulations
13.2.6 Regulatory Bodies
13.2.7 Major Associations
13.2.8 Taxes Levied
13.2.9 Corporate Tax Structure
13.2.10 Major companies
13.3 Eastern Europe Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.4 Eastern Europe Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.5 Eastern Europe Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.6 Eastern Europe Primary Biliary Cholangitis Market: Country Analysis
13.7 Russia Market
13.8 Russia Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.9 Russia Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
13.10 Russia Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14 North America Market
14.1 Summary
14.2 Market Overview
14.2.1 Region Information
14.2.2 Market Information
14.2.3 Background Information
14.2.4 Government Initiatives
14.2.5 Regulations
14.2.6 Regulatory Bodies
14.2.7 Major Associations
14.2.8 Taxes Levied
14.2.9 Corporate Tax Structure
14.2.10 Investments
14.2.11 Major Companies
14.3 North America Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.4 North America Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.5 North America Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.6 North America Primary Biliary Cholangitis Market: Country Analysis
14.7 USA Market
14.8 Summary
14.9 Market Overview
14.9.1 Country Information
14.9.2 Market Information
14.9.3 Background Information
14.9.4 Government Initiatives
14.9.5 Regulations
14.9.6 Regulatory Bodies
14.9.7 Major Associations
14.9.8 Taxes Levied
14.9.9 Corporate Tax Structure
14.9.10 Investments
14.9.11 Major Companies
14.10 USA Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.11 USA Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.12 USA Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.13 Canada Market
14.14 Summary
14.15 Market Overview
14.15.1 Country Information
14.15.2 Market Information
14.15.3 Background Information
14.15.4 Government Initiatives
14.15.5 Regulations
14.15.6 Regulatory Bodies
14.15.7 Major Associations
14.15.8 Taxes Levied
14.15.9 Corporate Tax Structure
14.15.10 Major Companies
14.16 Canada Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.17 Canada Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
14.18 Canada Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15 South America Market
15.1 Summary
15.2 Market Overview
15.2.1 Region Information
15.2.2 Market Information
15.2.3 Background Information
15.2.4 Government Initiatives
15.2.5 Regulations
15.2.6 Regulatory Bodies
15.2.7 Major Associations
15.2.8 Taxes Levied
15.2.9 Corporate Tax Structure
15.2.10 Investments
15.2.11 Major Companies
15.3 South America Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.4 South America Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.5 South America Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.6 South America Primary Biliary Cholangitis Market: Country Analysis
15.7 Brazil Market
15.8 Brazil Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.9 Brazil Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
15.10 Brazil Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16 Middle East Market
16.1 Summary
16.2 Market Overview
16.2.1 Region Information
16.2.2 Market Information
16.2.3 Background Information
16.2.4 Government Initiatives
16.2.5 Regulations
16.2.6 Regulatory Bodies
16.2.7 Major Associations
16.2.8 Taxes Levied
16.2.9 Corporate Tax Structure
16.2.10 Major Companies
16.3 Middle East Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.4 Middle East Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
16.5 Middle East Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17 Africa Market
17.1 Summary
17.2 Market Overview
17.2.1 Region Information
17.2.2 Market Information
17.2.3 Background Information
17.2.4 Government Initiatives
17.2.5 Regulations
17.2.6 Regulatory Bodies
17.2.7 Major Associations
17.2.8 Taxes Levied
17.2.9 Corporate Tax Structure
17.2.10 Major Companies
17.3 Africa Primary Biliary Cholangitis Market, Segmentation By Treatment Type, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.4 Africa Primary Biliary Cholangitis Market, Segmentation By Diagnosis, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
17.5 Africa Primary Biliary Cholangitis Market, Segmentation By End User, Historic And Forecast, 2019 – 2024, 2029F, 2034F, Value ($ Million)
18 Competitive Landscape and Company Profiles
18.1 Company Profiles
18.2 Intercept Pharmaceuticals Inc.
18.2.1 Company Overview
18.2.2 Products And Services
18.2.3 Business Strategy
18.2.4 Financial Overview
18.3 Mayo Clinic Laboratories
18.3.1 Company Overview
18.3.2 Products And Services
18.3.3 Business Strategy
18.3.4 Financial Overview
18.4 University of Pittsburgh Medical Center (UPMC)
18.4.1 Company Overview
18.4.2 Products And Services
18.4.3 Financial Overview
18.5 Stanford Health Care
18.5.1 Company Overview
18.5.2 Products And Services
18.5.3 Financial Overview
18.6 Duke University Hospital
18.6.1 Company Overview
18.6.2 Products And Services
18.6.3 Financial Overview
19 Other Major And Innovative Companies
19.1 UCLA Medical Center
19.1.1 Company Overview
19.1.2 Products and Services
19.2 King’s College Hospital
19.2.1 Company Overview
19.2.2 Products and Services
19.3 NewYork-Presbyterian Hospital
19.3.1 Company Overview
19.3.2 Products and Services
19.4 Cleveland Clinic
19.4.1 Company Overview
19.4.2 Products and Services
19.5 Johns Hopkins Hospital
19.5.1 Company Overview
19.5.2 Products and Services
19.6 GENFIT S.A
19.6.1 Company Overview
19.6.2 Products and Services
19.7 Ipsen Pharma SA
19.7.1 Company Overview
19.7.2 Products and Services
19.8 Gilead Sciences Inc.
19.8.1 Company Overview
19.8.2 Products and Services
19.9 Ascletis Pharma Inc.
19.9.1 Company Overview
19.9.2 Products and Services
19.10 Calliditas Therapeutics AB
19.10.1 Company Overview
19.10.2 Products and Services
19.11 Cour Pharmaceutical
19.11.1 Company Overview
19.11.2 Products and Services
19.12 GlaxoSmithKline plc (GSK)
19.12.1 Company Overview
19.12.2 Products and Services
19.13 HighTide Biopharma Inc.
19.13.1 Company Overview
19.13.2 Products and Services
19.14 Mirum Pharmaceuticals Inc.
19.14.1 Company Overview
19.14.2 Products and Services
19.15 NGM Biopharmaceuticals Inc.
19.15.1 Company Overview
19.15.2 Products and Services
20 Competitive Benchmarking
21 Competitive Dashboard
22 Key Mergers And Acquisitions
22.1 Gilead Sciences Acquired CymaBay Therapeutics
22.2 Alfasigma Acquired Intercept Pharmaceuticals
22.3 Ipsen Acquired Albireo Pharma
22.4 Advanz Pharma Corp. Limited Acquired Intercept Pharmaceuticals
23 Recent Development In Primary Biliary Cholangitis Market
23.1 Orphan Drug Designation To CNP-104 For Primary Biliary Cholangitis
23.2 FDA Grants Accelerated Approval To Seladelpar For Primary Biliary Cholangitis
24 Opportunities And Strategies
24.1 Global Primary Biliary Cholangitis Market In 2029 – Countries Offering Most New Opportunities
24.2 Global Primary Biliary Cholangitis Market In 2029 – Segments Offering Most New Opportunities
24.3 Global Primary Biliary Cholangitis Market In 2029 – Growth Strategies
24.3.1 Market Trend Based Strategies
24.3.2 Competitor Strategies
25 Primary Biliary Cholangitis Market, Conclusions And Recommendations
25.1 Conclusions
25.2 Recommendations
25.2.1 Product
25.2.2 Place
25.2.3 Price
25.2.4 Promotion
25.2.5 People
26 Appendix
26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer

Search Inside Report

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us